SLC3A2 and breast cancer: Immune cells among TME are associated with the hallmarks of BC 3, we continued to evaluate the biomarker relevance of SLC3A2 compared to standardized cancer biomarkers in immune checkpoint blockade sub-cohorts using TIDE database.